Injection 99% Pharmaceutical Material USP Standard Abiraterone 154229-19-3 - 154229-19-3
Injection 99% Pharmaceutical Material USP Standard Abiraterone 154229-19-3 For Sale, Most Competitive Price, Fast Delivery, Custom Service, Wholesale Injection 99% Pharmaceutical Material USP Standard Abiraterone 154229-19-3, Made in China, High Quality Products!, China Steroids, chemical Supplier, Manufacturer.
Injection 99% Pharmaceutical Material USP Standard Abiraterone 154229-19-3
Basic Info.
Abiraterone
Alias : 17-(3-Pyridyl)androsta-5,16-dien-3beta-ol
CAS: 154229-19-3
Molecular Formula: C24H31NO
Molecular Weight: 349.51
Assay: 99%
Appearance: White powder
Grade: Pharmaceutical Grade
Storage: Shading, confined preservation
Usage: It is indicated for use in combination with prednisone as a treatment for metastatic castration-resistant prostate
Product Description:
Abiraterone is a drug used in combination with prednisone in metastatic castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) -- i.e., prostate cancer not responding to androgen deprivation or treatment with antiandrogens. It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. Cadila Pharmaceuticals has recently started marketing Abiraterone acetate under the trade name Abretone.
After an expedited six-month review, abiraterone was approved by the U.S. Food and Drug Administration (FDA) in April 2011. In Phase III trials, it extended median survival to 14.8 months versus 10.9 months placebo, and the trial was stopped because of the successful outcome.
Application:
It is indicated for use in combination with prednisone as a treatment for metastatic castration-resistant prostate cancer. It has received FDA (28 April 2011), EMA (23 September 2011), MHRA (5 September 2011) and TGA (1 March 2012) approval for this indication. In Australia it is covered by the Pharmaceutical Benefits Scheme when being used to treat castration-resistant prostate cancer and given in combination with prednisone/prednisolone (subject to the conditions that the patient is not currently receiving chemotherapy, is either resistant or intolerant of docetaxel, has a WHO performance status of <2, and his disease has not since become progressive since treatment with PBS-subsidised abiraterone has commenced).
Guangzhou Kafen Biotech Co., Ltd.
Address: No. 128, Hanxing East Rd, Zhongcun, Panyu District,, Guangzhou, GuangDong, China, 511495
Tel: +8618022403273
Guangzhou Kafen Biotech Co., Ltd is a high-tech and professional company founded in 2002, which specialized in developing, manufacturing, distributing steroid hormone powders and intermediates. We have been devoted in R&D, production and marketing steroid hormone and pharmaceutical raw materials.
With advanced production technology and equipment, strong technical force, first-class laboratory and inspection equipment. Kafen has developed into a professional factory manufacturing anabolic steroid powders with several years'efforts and contribution of experienced technicians in different areas. Company affiliated factory has advanced production equipment and plants, perfect quality assurance and control system, whole set of High Pressure Liquid Chromatography/Gas Chromatography/UV Spectrophotometer to conduct effective product analysis and monitoring. Company factory has passed ISO9001 quality system certification and international KOSHER certification.
Now, we continues its high speed development and contributes a lot to its new products' R&D and quality improvement. Under the credibility and win-win principle, kafen biotech will devote to culture innovation to provide excellent products and best service to our customers.
Related Products
